- ICH GCP
- Amerikanska kliniska prövningsregistret
- Search trials
Clinical Trials on Högrisk lokaliserad prostatacancer in China
Totalt 410 resultat
-
The First Affiliated Hospital of Xiamen UniversityRekryteringMetastaserande kastrationsresistent prostatacancer, mCRPCKina
-
Fudan UniversityOkändProstatacancer MetastaserandeKina
-
Shanghai Junshi Bioscience Co., Ltd.OkändCOVID 19; och hög infektionsrisk för SARS-CoV-2Kina
-
Affiliated Hospital to Academy of Military Medical...OkändHögrisk mjukvävnadssarkomKina
-
Shanghai Jiao Tong University School of MedicineFudan University; Qilu Hospital of Shandong UniversityRekrytering
-
Lei LiOkändLivmoderhalscancer | Cervikal intraepitelial neoplasi | DNA-metylering | Cytologi | Humant papillomvirus med hög riskKina
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...RekryteringKemoterapi effekt | Brist på reparation av DNA-skador | Kemoterapeutisk toxicitet | Hormonkänslig metastatisk prostatacancerKina
-
Jiangsu HengRui Medicine Co., Ltd.AvslutadHormonkänslig prostatacancerKina
-
RenJi HospitalChanghai Hospital; Peking University People's Hospital; Shanghai Zhongshan... och andra samarbetspartnersRekrytering
-
Shanghai General Hospital, Shanghai Jiao Tong University...NanoMab Technology (UK) LimitedAvslutad
-
Tianjin Medical University Second HospitalOkänd
-
Peking Union Medical College HospitalNational Institute for Biomedical Imaging and Bioengineering (NIBIB)Okänd
-
Xinhua Hospital, Shanghai Jiao Tong University...Okänd
-
West China HospitalRekryteringKemoradioterapi | Total Neoadjuvant Behandling | Local Advanced Rectal Cancer | High Risk FactorsKina
-
Luye Pharma Group Ltd.Har inte rekryterat ännu
-
Peking Union Medical College HospitalRekrytering
-
Peking Union Medical College HospitalRekrytering
-
Peking Union Medical College HospitalRekrytering
-
Tianjin Medical University Second HospitalTianjin Medical University General Hospital; Tianjin First Central Hospital och andra samarbetspartnersHar inte rekryterat ännu
-
Luye Pharma Group Ltd.Avslutad
-
Fudan UniversityAktiv, inte rekryterande
-
Second Military Medical UniversityPeking Union Medical College Hospital; RenJi Hospital; Zhejiang UniversityOkänd
-
Second Military Medical UniversityAvslutad
-
Ferring PharmaceuticalsAvslutad
-
Peking Union Medical College HospitalNational Institute for Biomedical Imaging and Bioengineering (NIBIB)Okänd
-
The First Affiliated Hospital of Soochow UniversityRekryteringHögrisk Akut Myeloid Leukemi | Medellång risk Akut myeloid leukemiKina
-
The First Affiliated Hospital with Nanjing Medical...RekryteringMetastaserad prostatacancer | Terapi, direkt observeradKina
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRekryteringProstatiska neoplasmer | Metastaserande kastrationsresistent prostatacancerKina
-
Shanghai East HospitalRekrytering
-
Fudan UniversityRekrytering
-
Shanghai East HospitalHar inte rekryterat ännu
-
Peking Union Medical College HospitalRekrytering
-
Shanghai East HospitalHar inte rekryterat ännu
-
Luye Pharma Group Ltd.Avslutad
-
First Affiliated Hospital Xi'an Jiaotong UniversityRekrytering
-
First Affiliated Hospital Xi'an Jiaotong UniversityHar inte rekryterat ännu
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...First Affiliated Hospital of Zhejiang University; The First Affiliated...Rekrytering
-
Qilu Hospital of Shandong UniversityZibo Central HospitalRekrytering
-
Xiangya Hospital of Central South UniversityRekrytering
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Rekrytering
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Okänd
-
Lee's Pharmaceutical LimitedOkänd
-
Third Affiliated Hospital, Sun Yat-Sen UniversityOkänd
-
The First Affiliated Hospital with Nanjing Medical...RekryteringMetastaserad prostatacancer | Intermitent anti-androgen terapiKina
-
BayerAvslutadBenmetastaser | Metastaserande kastrationsresistent prostatacancerKina
-
Changhai HospitalRekrytering
-
Xinhua Hospital, Shanghai Jiao Tong University...Rekrytering
-
Jiangsu HengRui Medicine Co., Ltd.Anmälan via inbjudanHormonreceptorpositiv, mänsklig epidermal receptor 2 negativ, nodpositiv, högrisk, tidigt stadium,bröstcancer hos kvinnorKina